Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Diluted Average) (2021 - 2025)

CorMedix has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $71.9 million for Q2 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $71.9 million for Q2 2025, up 24.94% from a year ago — trailing twelve months through Jun 2025 was $71.9 million (up 24.94% YoY), and the annual figure for FY2024 was $58.9 million, up 15.65%.
  • Shares Outstanding (Diluted Average) reached $71.9 million in Q2 2025 per CRMD's latest filing, up from $69.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $71.9 million in Q2 2025 and bottomed at $37.5 million in Q3 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $45.4 million (2023), compared with a mean of $49.0 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) grew 2.43% in 2022 before it skyrocketed 30.42% in 2024.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $37.7 million in 2021, then rose by 6.92% to $40.3 million in 2022, then grew by 26.39% to $50.9 million in 2023, then grew by 15.65% to $58.9 million in 2024, then increased by 22.16% to $71.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CRMD at $71.9 million in Q2 2025, $69.0 million in Q1 2025, and $58.9 million in Q4 2024.